What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Professionals Lidia Fuertes Rioja Professionals Anna Roig Pratdepadua Professionals Marta Pinsach Batet Year 2024 Data d'inici Thu, 14 Mar 2024 - 12:00 Data de tancament Thu, 4 Apr 2024 - 12:00 Descripció Pre-Award Research Officer_2024102 Codi 2024-102 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0102//2024_0102_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Wed, 1 May 2024 - 12:00 Descripció International Post-Award Research Manager Codi 2024-99 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0099//2024_0099_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 12 Mar 2024 - 12:00 Data de tancament Tue, 2 Apr 2024 - 12:00 Descripció Bioinformatics Technician - UEB Codi 2024-100 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0100//2024_0100_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 12 Mar 2024 - 12:00 Data de tancament Tue, 26 Mar 2024 - 12:00 Descripció Junior Innovation Manager_20240101 Codi 2024-101 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0101//2024_0101_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Mon, 1 Apr 2024 - 12:00 Grup de recerca Shock, Organ Dysfunction and Resuscitation Descripció Data Science-Intensive Care Unit/ Shock, Organ Dysfunction and Resuscitation Group_20240095 Codi 2024-95 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0095//2024_0095_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Tue, 26 Mar 2024 - 12:00 Grup de recerca Maternal and Fetal Medicine Descripció Auxiliary Nursing Care Technician (TCAE) Assisted reproduction and gynecological endocrinology Unit_20240096 Codi 2024-96 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0096//2024_0096_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Fri, 10 May 2024 - 12:00 Grup de recerca Maternal and Fetal Medicine Descripció Clinical Researcher, Maternal-Fetal Medicine Unit Assisted reproduction and gynecological endocrinology Unit _20240097 Codi 2024-97 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0097//2024_0097_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Thu, 25 Apr 2024 - 12:00 Grup de recerca Rheumatology Descripció Clinical Research Monitor Rheumatology Research Group_20240098 Codi 2024-98 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0098//2024_0098_001.pdf Reclutant Inactiu Seguridad, tolerancia y actividad antirretroviral de dasatinib: estudio clínico piloto enpacientes con infección reciente por el VIH-1 Contact Protocol code: DASAHIVCURE EudraCT code: 2021-001288-26 Pathology: Certes malalties infeccioses i parasitàries Principal investigator: Falcó Ferrer, Vicenç Research group: Malalties infeccioses Service: Infeccioses Phase: Fase IV Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de cohortes de fase 2, con un solo grupo, abierto para evaluar la seguridad, la eficacia y lafarmacocinética del tratamiento con esparsentán en pacientes pediátricos con determinadasenfermedades glomerulares proteinúricas (EPPIK). Contact Protocol code: RTRX-RE021-201 EudraCT code: 2021-000621-27 Pathology: Malalties del sistema genitourinari Principal investigator: Ariceta Iraola, Gema Research group: Fisiopatologia renal Service: Nefrologia Pediàtrica Phase: Fase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO DE FASE III ALEATORIZADO, ABIERTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE GIREDESTRANT EN COMBINACIÓN CON PHESGO COMPARADO CON PHESGO TRAS TRATAMIENTO DE INDUCCIÓN CON PHESGO + TAXANO EN PACIENTES CON CÁNCER DE MAMA LOCALMENTE AVANZADO O METASTÁSICO HER2 POSITIVO Y RECEPTOR DE ESTRÓGENOS POSITIVO, NO TRATADOS PREVIAMENTE Contact Protocol code: WO43571 EudraCT code: No aplica Pathology: Tumors Principal investigator: Escriva de Romaní Muñoz, Santiago Ignacio Service: Oncologia Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio fase III, multicéntrico, aleatorizado, doble ciego, dosis crónica, de grupos paralelos y controlado con placebo para evaluar la eficacia y seguridad de Tozorakimab en pacientes con enfermedad pulmonar obstructiva crónica (EPOC) sintomática y con historial de exacerbaciones de la EPOC Contact Protocol code: D9180C00012 EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: Barrecheguren Fernández, Miriam Research group: Pneumologia Service: Pneumologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio internacional, de fase 2b, aleatorizado ydoble ciego para investigar la eficacia y la seguridad de redasemtide (S-005151) comparado con placebo enpacientes mayores de edad con ictus isquémico agudo que no son candidatos a tratamiento con activadortisular del plasminógeno o trombectomía Contact Protocol code: 2138P2231 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Molina Cateriano, Carlos Research group: Recerca en ictus Service: Neurologia Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio aleatorizado, doble ciego, controlado con placebo, de grupos paralelos que evalúa los efectos del fármaco oral BI685509 (ajuste de dosis a un régimen de dosis fija) en hipertensión portal después de 8 semanas de tratamiento en pacientes con hipertensión clínicamente significativa (CSPH) en cirrosis descompensada después de su primer evento de descompensación, estabilizados CTP 5-7. Contact Protocol code: 1366-0055 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Pericàs Pulido, Juan Manuel Research group: Malalties hepàtiques Service: Sense classificar Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO EN FASE III, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE EFRUXIFERMIN EN SUJETOS CON ESTEATOHEPATITIS NO ALCOHÓLICA (EHNA) NO CIRRÓTICA Y FIBROSIS Contact Protocol code: AK-US-001-0105 EudraCT code: No aplica Pathology: Tumors Principal investigator: Pericàs Pulido, Juan Manuel Research group: Liver Diseases Service: Hepatologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A SINGLE-ARM, OPEN-LABEL, MULTI-CENTRE, PHASE IB STUDY EVALUATING THE SAFETY AND PRELIMINARY EFFICACY OF AUTO1 IN PAEDIATRIC PATIENTS WITH CD19-POSITIVE RELAPSED/ REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B ALL) AND AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA (B NHL) Contact Protocol code: AUTO1-PY1 EudraCT code: No aplica Pathology: Tumors Principal investigator: Díaz de Heredia Rubio, Maria Cristina Research group: Càncer i malalties hematològiques infantils Service: Oncohematologia Pediàtrica Phase: Fase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio fase 2/3, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos para evaluar la eficacia y la seguridad de belimumab ..administrado por vía subcutánea en adultos con enfermedad pulmonar intersticial asociada a esclerosis sistémica (SSc-ILD). Contact Protocol code: 218224 EudraCT code: No aplica Pathology: Diseases of the respiratory system Principal investigator: Guillen Del Castillo, Alfredo Research group: Malalties sistèmiques Service: Medicina Interna Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Pagination First page « Previous page ‹ … Page 1427 Page 1428 Current page 1429 Page 1430 Page 1431 … Next page › Last page »
Year 2024 Data d'inici Thu, 14 Mar 2024 - 12:00 Data de tancament Thu, 4 Apr 2024 - 12:00 Descripció Pre-Award Research Officer_2024102 Codi 2024-102 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0102//2024_0102_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Wed, 1 May 2024 - 12:00 Descripció International Post-Award Research Manager Codi 2024-99 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0099//2024_0099_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 12 Mar 2024 - 12:00 Data de tancament Tue, 2 Apr 2024 - 12:00 Descripció Bioinformatics Technician - UEB Codi 2024-100 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0100//2024_0100_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 12 Mar 2024 - 12:00 Data de tancament Tue, 26 Mar 2024 - 12:00 Descripció Junior Innovation Manager_20240101 Codi 2024-101 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0101//2024_0101_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Mon, 1 Apr 2024 - 12:00 Grup de recerca Shock, Organ Dysfunction and Resuscitation Descripció Data Science-Intensive Care Unit/ Shock, Organ Dysfunction and Resuscitation Group_20240095 Codi 2024-95 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0095//2024_0095_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Tue, 26 Mar 2024 - 12:00 Grup de recerca Maternal and Fetal Medicine Descripció Auxiliary Nursing Care Technician (TCAE) Assisted reproduction and gynecological endocrinology Unit_20240096 Codi 2024-96 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0096//2024_0096_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Fri, 10 May 2024 - 12:00 Grup de recerca Maternal and Fetal Medicine Descripció Clinical Researcher, Maternal-Fetal Medicine Unit Assisted reproduction and gynecological endocrinology Unit _20240097 Codi 2024-97 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0097//2024_0097_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 11 Mar 2024 - 12:00 Data de tancament Thu, 25 Apr 2024 - 12:00 Grup de recerca Rheumatology Descripció Clinical Research Monitor Rheumatology Research Group_20240098 Codi 2024-98 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0098//2024_0098_001.pdf Reclutant Inactiu
